Brooktree Capital Management Abbott Laboratories Transaction History

Brooktree Capital Management

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$90.19 - $110.4 $1,533 - $1,876	-17 Reduced 0.64%	2,644 $291,000
Q1 2023 May 08, 2023	SELL	$96.86 - $114.01 $250,383 - $294,715	-2,585 Reduced 49.28%	2,661 $269,000
Q4 2022 Feb 07, 2023	SELL	$95.06 - $111.52 $352,672 - $413,739	-3,710 Reduced 41.42%	5,246 $576,000
Q3 2022 Nov 07, 2022	SELL	$96.76 - $112.03 $68,796 - $79,653	-711 Reduced 7.35%	8,956 $867,000
Q2 2022 Aug 08, 2022	SELL	$102.07 - $123.37 $93,802 - $113,377	-919 Reduced 8.68%	9,667 $1.05 Million
Q1 2022 May 09, 2022	SELL	$114.02 - $139.04 $275,130 - $335,503	-2,413 Reduced 18.56%	10,586 $1.25 Million
Q4 2021 Feb 07, 2022	SELL	$115.53 - $141.46 $18,138 - $22,209	-157 Reduced 1.19%	12,999 $1.83 Million
Q3 2021 Nov 09, 2021	SELL	$116.66 - $129.06 $112,576 - $124,542	-965 Reduced 6.83%	13,156 $1.55 Million
Q1 2021 May 03, 2021	SELL	$108.84 - $128.23 $70,746 - $83,349	-650 Reduced 4.4%	14,121 $1.69 Million
Q4 2020 Feb 03, 2021	SELL	$105.0 - $114.42 $71,085 - $77,462	-677 Reduced 4.38%	14,771 $1.62 Million
Q3 2020 Nov 09, 2020	SELL	$91.64 - $111.29 $23,459 - $28,490	-256 Reduced 1.63%	15,448 $1.68 Million
Q2 2020 Aug 03, 2020	SELL	$76.57 - $98.0 $3,215 - $4,116	-42 Reduced 0.27%	15,704 $1.44 Million
Q1 2020 May 06, 2020	SELL	$62.82 - $91.86 $3,455 - $5,052	-55 Reduced 0.35%	15,746 $1.24 Million
Q4 2019 Feb 26, 2020	BUY	$78.51 - $87.4 $1.24 Million - $1.38 Million	15,801 New	15,801 $1.37 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Brooktree Capital Management, based on Form 13F filings with the SEC.

Stay updated on Brooktree Capital Management with notifications on news.